Cargando…
Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report
We report here a 66-year-old woman diagnosed with bronchioloalveolar carcinoma of the right lung cT4N2M0. The patient was from the Philippines, had never smoked, and tested positive for an EGFR mutation. She received gefitinib as neoadjuvant therapy for two months and displayed a partial response. T...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949555/ https://www.ncbi.nlm.nih.gov/pubmed/26029620 http://dx.doi.org/10.1016/j.rmcr.2013.02.002 |